XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.4

Expenses (Tables)

6 Months Ended

Dec. 31, 2022

Text block [abstract]

Summary of expenses

		Consolidated
		December 2022 $				December 2021 Restated * $
Loss before income tax includes the following specific expenses:
Amortisation
Paxalisib licensing agreement			542,177				542,177
EVT-801 licensing agreement			392,534				392,534
Total amortisation			934,711				934,711
Interest expense
Contingent consideration			221,637				207,068
Superannuation expense
Defined contribution superannuation expense			63,734				93,960
Employee benefits expense excluding superannuation
Employee benefits expense excluding superannuation			1,778,503				1,349,523

X

- Definition

The disclosure of expenses by nature. [Refer: Expenses, by nature]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfExpensesByNatureExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Text block [abstract]

+ References

No definition available.

+ Details

Name:	kzia_TextBlockAbstract
Namespace Prefix:	kzia_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration